Electra targets $342m IPO to fund hyperinflammatory syndrome drug’s pivotal trials
Read the full story on Yahoo Finance →
Opens the original article on finance.yahoo.com
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.